Author:
Cipriani Paola,Berardicurti Onorina,Masedu Francesco,D’Onofrio Francesca,Navarini Luca,Ruscitti Piero,Maruotti Nicola,Margiotta Domenico Paolo Emanuele,Liakouli Vasiliki,Di Benedetto Paola,Carubbi Francesco,Valenti Marco,Cantatore Francesco Paolo,Afeltra Antonella,Giacomelli Roberto
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference48 articles.
1. Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK et al (2011) Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev 16:CD008794
2. Listing J, Gerhold K, Zink A (2013) The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford) 52:53–61
3. Ruderman EM (2012) Overview of safety of non-biologic and biologic DMARDs. Rheumatology (Oxford) 51:vi37–vi43
4. Singh JA, Cameron C, Noorbaloochi S, Cullis T, Tucker M, Christensen R et al (2015) Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet 18(386):258–265
5. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275–2285
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献